市场调查报告书
商品编码
1597086
北美眼科设备市场预测至 2031 年 - 区域分析 - 按产品、应用和最终用户North America Ophthalmology Devices Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User |
2023年北美眼科器械市场价值为172.2121亿美元,预计到2031年将达到329.590亿美元;预计 2023 年至 2031 年复合年增长率为 8.5%。
对眼科护理服务远距医疗的日益关注推动了北美眼科设备市场
随着影像撷取和资料传输技术的进步,眼科正在大力拥抱远距医疗整合。随着智慧型手机和第五代 (G) 无线通讯的快速使用,远端眼科技术(称为远端眼科)的采用迅速发展。远距眼科可非同步(储存转发)和同步(即时)用于眼部疾病的诊断、筛检、监测和治疗,例如老年黄斑部病变、糖尿病视网膜病变、青光眼、神经眼科疾病和小儿眼部疾病,包括早产儿视网膜病变。此外,远距医疗与眼科的整合在改善筛检程序和治疗的可近性方面具有巨大的潜力。透过这种方法实现的远端患者监控提高了眼科护理服务的整体品质。远距医疗和远距眼科已经存在多年,但在 COVID-19 大流行期间,这些做法变得非常重要。因此,已开发国家和发展中国家远距眼科的采用预计将在未来几年为眼科设备市场带来显着的成长趋势。
北美眼科设备市场概况
2023年北美眼科设备市场价值为172.2121亿美元,预计2031年将达到329.5900亿美元;预计 2023-2031 年复合年增长率为 8.4%。北美眼科设备市场的成长归因于人口老化的加剧和眼部疾病盛行率的增加。
根据人口资料局2019 年的数据,到2060 年,美国65 岁及以上的人口数量预计将从2018 年的5,200 万人(占总人口的16%)增加一倍,达到近9,500 万(占总人口的23%)根据美国眼科学会 2019 年的研究,预计到 2050 年,美国将有 732 万名 70-75 岁的人受到原发性开角型青光眼 (POAG) 的影响。
视力障碍和视力不佳等眼部疾病是美国眼科手术数量激增的主要原因。根据 Starsurgical 2023 年投资人介绍,美国每年进行近 300 万例屈光手术。眼科设备市场的公司正在采取各种有机和无机成长策略;下面提到了最近发生的一些事例。
2023 年 9 月,OCULUS, Inc. 与 LUVO 合作,在美国验光和眼科市场推出两款新型患者治疗设备-DARWIN 和 LUCENT。 LUCENT IPL、DARWIN IPL 和 RF 设备旨在为眼科护理人员提供有效且舒适的治疗方式,从而针对患者症状的根本原因。
此外,根据加拿大统计局的估计,到 2036 年,老年人预计将占加拿大人口的 23-25%,到 2061 年将占加拿大人口的 24-28%。由于人口老化,眼部疾病的发生率很高。
北美眼科设备市场收入及 2031 年预测(百万美元)
北美眼科设备市场细分
北美眼科设备市场根据产品、应用、最终用户和国家进行细分。
根据产品,北美眼科设备市场分为视力保健产品、手术设备以及诊断和监测设备。 2023 年,视力保健产品领域占最大份额。
在应用方面,北美眼科设备市场分为白内障、青光眼、难治性疾病、玻璃体视网膜疾病和其他应用。 2023 年,青光眼细分市场占最大份额。
按最终用户划分,北美眼科设备市场分为医院和眼科诊所、学术和研究实验室以及其他最终用户。 2023 年,医院和眼科诊所占据最大份额。
按国家/地区划分,北美眼科设备市场分为美国、加拿大和墨西哥。 2023年,美国在北美眼科设备市场占据主导地位。
北美眼科设备市场的主要参与者包括强生视力保健公司、爱尔康公司、卡尔蔡司医疗公司、博士伦公司、依视路Intonational SAS、尼德克有限公司、拓普康公司、Haag-Streit AG、 Ziemer Ophthalmic Systems AG 、和 Hoya Corp 是北美眼科设备市场上的一些领先公司。
The North America ophthalmology devices market was valued at US$ 17,221.21 million in 2023 and is expected to reach US$ 32,959.00 million by 2031; it is estimated to register at a CAGR of 8.5% from 2023 to 2031.
Growing Focus on Telemedicine for Eye Care Services Fuels North America Ophthalmology Devices Market
With technological advancements in image capturing and data transmission, ophthalmology is strongly embracing telehealth integration. The adoption of technology in delivering remote eye care, known as teleophthalmology, has evolved rapidly with the rapid usage of smartphones and 5th generation (G) wireless communications. Teleophthalmology can be used both asynchronously (store-and-forward) and synchronously (real-time) in the diagnosis, screening, monitoring, and treatment of eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma, neuro-ophthalmic disorders, and pediatric ocular diseases, including the retinopathy of prematurity. Moreover, the integration of telehealth in ophthalmology presents strong potential to improve access to screening procedures and treatments. Remote patient monitoring, enabled by this approach, enhances the overall quality of eye care services. Telemedicine and teleophthalmology are already in place since many years, but the practices gained significant importance during the COVID-19 pandemic. Hence, the adoption of teleophthalmology, in both developed and developing countries is expected to bring significant growth trends in the ophthalmology devices market in the coming years.
North America Ophthalmology Devices Market Overview
The North America Ophthalmology Devices market was valued at US$ 17,221.21 million in 2023 and is projected to reach US$ 32,959.00 million by 2031; it is expected to register a CAGR of 8.4% during 2023-2031. The ophthalmology devices market growth in North America is attributed to the rising aging population and the increasing prevalence of eye diseases.
As per the Population Reference Bureau 2019, the number of individuals in the US aged 65 and older is estimated to double from 52 million (16% of the total population) in 2018 to nearly 95 million (23% of the total population) by 2060. As per the American Academy of Ophthalmology's 2019 study, an estimated 7.32 million people aged 70-75 would be affected by primary open-angle glaucoma (POAG) in the US by 2050.
Eye conditions such as vision impairment and poor vision are the prominent causes of a surging number of eye surgeries in the US. According to the 2023 investors' presentation of Starsurgical, nearly 3000,000 refractive procedures are performed in the US every year. Companies in the ophthalmology devices market are adopting various organic and inorganic growth strategies; a few of the recent instances are mentioned below.
In September 2023, OCULUS, Inc. partnered with LUVO to introduce two new patient treatment devices-the DARWIN and LUCENT-in the US optometry and ophthalmology market. The LUCENT IPL, and DARWIN IPL and RF devices are intended to offer eye care practitioners effective and comfortable treatment modalities that can target the root causes of patient symptoms.
Furthermore, according to the Statistics Canada estimates, seniors are expected to comprise ~23-25% of the Canadian population by 2036 and ~24-28% of the population by 2061. The rising geriatric population is expected to propel the adoption of ophthalmology devices as the aging population is highly prone to eye diseases.
North America Ophthalmology Devices Market Revenue and Forecast to 2031 (US$ Million)
North America Ophthalmology Devices Market Segmentation
The North America ophthalmology devices market is segmented based on product, application, end user, and country.
Based on product, the North America ophthalmology devices market is segmented into vision care products, surgical devices, and diagnostics and monitoring devices. The vision care products segment held the largest share in 2023.
In terms of application, the North America ophthalmology devices market is segmented into cataract, glaucoma, refractory disorders, vitreoretinal disorders, and other applications. The glaucoma segment held the largest share in 2023.
By end user, the North America ophthalmology devices market is segmented into hospital and eye clinics, academic and research laboratories, and other end users. The hospital and eye clinics segment held the largest share in 2023.
Based on country, the North America ophthalmology devices market is categorized into US, Canada, and Mexico. The US dominated the North America ophthalmology devices market in 2023.
Key players operating in the North America ophthalmology devices market are Johnson & Johnson Vision Care Inc, Alcon AG, Carl Zeiss Meditec, Bausch & Lomb Inc, Essilor Intonational SAS, Nidek Co Ltd, Topcon Corp, Haag-Streit AG, Ziemer Ophthalmic Systems AG, and Hoya Corp are some of the leading companies operating in the North America ophthalmology devices market.